600 filings
Page 15 of 30
8-K
7wezre9mftpsbhajo
14 Apr 14
NW Bio Announces Financing of Up to $32 Million
12:00am
424B5
gb5psgt7n9e 6db4mrif
11 Apr 14
Prospectus supplement for primary offering
12:00am
NT 10-K
gp2q5 knqj49o6af
31 Mar 14
Notice of late annual filing
12:00am
8-K
eambfieml
13 Mar 14
NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board’s Safety Review
12:00am
8-K
e19af
24 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
sjc8ic
27 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
fw4q9821bai
25 Nov 13
Other Events
12:00am
424B5
a44zpe
21 Nov 13
Prospectus supplement for primary offering
12:00am
8-K
i0x0l56ijkoa7desfm
20 Nov 13
Proposed Public Offering of Common Stock and Warrants
12:00am
424B5
kaj 0p3wkouv5h9wxqr
19 Nov 13
Prospectus supplement for primary offering
12:00am
NT 10-Q
0g3t2v
14 Nov 13
Notice of late quarterly filing
12:00am
8-K
grd of9vr
16 Sep 13
Other Events
12:00am
8-K
i31 xxpsl
9 Aug 13
Northwest Biotherapeutics Announces Registered Direct Offering
12:00am
424B5
p6sdplg2xdxs pa
9 Aug 13
Prospectus supplement for primary offering
12:00am
8-K
p6phf6qhp1
9 Aug 13
Other Events
12:00am
8-K
hf8m pwln619wc8ud6fo
31 Jul 13
Changes in Registrant's Certifying Accountant
12:00am